Banyan Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Banyan Capital Management's ABBV Position: Q3 2026 in Review
Banyan Capital Management reduced its AbbVie (ABBV) stake by 3.4% in Q3 2026, selling an estimated $25.6K and leaving 2,819 shares worth $737K. The position accounts for 0.32% of the portfolio, ranked #26.
Banyan Capital Management first reported a position in ABBV in Q3 2025 and has held it in 5 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Banyan Capital Management held 2,819 shares of AbbVie worth $737K as of Q3 2026.
- Banyan Capital Management sold 100 AbbVie shares in Q3 2026, an estimated $25.6K.
- AbbVie made up 0.32% of Banyan Capital Management's portfolio in Q3 2026, its #26 holding.
- Banyan Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 5 quarters since.
- 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Banyan Capital Management's 13F filing for Q3 2026, filed 5 Nov 2026.